Cross Country Healthcare Q1 2026 revenue down 18% YoY, net loss widens to $4.3M

CROSS COUNTRY HEALTHCARE INC

2026-Q1 EPS reported -$0.14 revenue$241,057,000

Revenue $241.1M, down 18% YoY; gross profit margin 19.7%, down 30 bps.
Net loss attributable to common stockholders $4.3M vs $0.5M loss in Q1 2025.
Diluted EPS loss $0.14; adjusted EPS loss $0.03.
Adjusted EBITDA $3.9M, down 55% YoY; adjusted EBITDA margin 1.6%.
Cash flow from operations $4.8M, down 16% YoY.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CROSS COUNTRY HEALTHCARE INC reported first quarter ended March 31, 2026 results: revenue $241,057, net income Net loss attributable to common stockholders $ (4,266), EPS Diluted EPS $ (0.14).

Period: first quarter ended March 31, 2026
Revenue: $241,057
Net income: Net loss attributable to common stockholders $ (4,266)
EPS: Diluted EPS $ (0.14)
Result: reported results

Exact text from the filing

ended March 31, 2026. Selected Financial Information: Variance Variance Q1 2026 vs Q1 2026 vs Dollars are in thousands, except per share amounts Q1 2026 Q1 2025 Q4 2025 Revenue $ 241,057 (18) % 2 % Gross profit margin* 19.7 % (30) bps (60) bps Net loss attributable to common stockholders $ (4,266) (771) % 95 % Diluted EPS $ (0.14) $ (0.12) $ 2.42 Adjusted EBITDA*

View on SEC.gov

Browse all earnings releases →

CROSS COUNTRY HEALTHCARE INC filing history →

Source: SEC EDGAR

accession 0001628280-26-032217

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.